Immediately Contact Your Prescribing Physician and Do Not Take Your Next Dose Until Evaluated
If you are experiencing palpitations and racing heart on Vyvanse 40 mg, you need urgent medical evaluation before continuing this medication. These cardiovascular symptoms require immediate assessment to rule out serious cardiac complications.
Immediate Actions Required
Contact your healthcare provider today or go to urgent care/emergency department if symptoms are severe. The FDA drug label explicitly warns that lisdexamfetamine (Vyvanse) should be avoided in patients with serious cardiac disease and requires monitoring of blood pressure and heart rate 1. Your symptoms of palpitations and racing heart are recognized cardiovascular adverse events that warrant immediate clinical attention 1.
Why This Is Urgent
- Stimulants like Vyvanse increase heart rate and blood pressure 2, 1
- While mild increases (1-2 beats per minute) are common and clinically insignificant, 5-15% of patients experience more substantial cardiovascular changes 2
- Your symptomatic palpitations and racing heart suggest you may be in this higher-risk subset
- The FDA specifically lists increased heart rate as a common adverse reaction and mandates blood pressure and pulse monitoring 1
What Your Doctor Will Need to Assess
Your physician must evaluate:
Cardiac history screening - personal or family history of:
- Structural cardiac abnormalities
- Cardiomyopathy
- Serious arrhythmias
- Sudden cardiac death
- Long QT syndrome, Wolff-Parkinson-White syndrome, or hypertrophic cardiomyopathy 2
Vital signs measurement - current heart rate and blood pressure 1
ECG if indicated - particularly if risk factors are present 2
Medication review - other drugs that could interact or compound cardiovascular effects 3, 4
Management Options Your Doctor May Consider
Option 1: Dose Reduction
If cardiovascular evaluation is reassuring, reducing from 40 mg to 30 mg may alleviate symptoms while maintaining therapeutic benefit 1. Research shows cardiovascular effects are dose-dependent 5.
Option 2: Switch to Non-Stimulant
If symptoms persist or cardiac concerns exist, switching to atomoxetine, guanfacine, or clonidine eliminates stimulant-related cardiovascular effects 2, 6. These non-stimulants are specifically recommended as alternatives when stimulants cause problematic side effects 2.
Option 3: Different Stimulant Formulation
Switching to methylphenidate-based medications may be considered, as individual responses to different stimulant classes vary 2, 6.
Option 4: Discontinuation
If you have undiagnosed cardiac disease, Vyvanse should be discontinued 1. The FDA contraindication is absolute for patients with serious cardiac conditions 1.
Critical Safety Points
- Never ignore cardiovascular symptoms on stimulants - while rare, sudden cardiac death has been reported, particularly in those with underlying heart disease 2, 4
- Do not simply "push through" these symptoms - they indicate your cardiovascular system is responding adversely
- Do not adjust the dose yourself - requires medical supervision and proper cardiac evaluation first
- Research in healthy adults showed pulse increases of 2.8-5.2 bpm were common 5, but symptomatic palpitations warrant evaluation regardless of objective measurements
Common Pitfall to Avoid
Do not assume these symptoms will resolve with continued use. While some ADHD medication side effects diminish over time, cardiovascular symptoms that are bothersome require immediate medical attention 2, 1. The 2019 AAP guidelines emphasize that while stimulants are generally safe, monitoring is essential specifically because a subset of patients experience clinically significant cardiovascular changes 2.
Bottom line: Stop your medication and call your doctor today. Your symptoms require evaluation before you can safely continue Vyvanse or determine if an alternative treatment is needed.